HBP.CA Profile & Description — Helix BioPharma Corp
Helix BioPharma Corp. is a biopharmaceutical company specializing primarily in the field of cancer therapy. Co. is engaged in developing innovative products for the treatment and prevention of cancer based on its proprietary technologies. Co.'s product development initiatives are focused primarily on its L-DOS47 and Topical Interferon Alpha-2b drugs. In addition, Co. distributes Orthovisc® and MonoviscTM , treatments for osteoarthritis of the knee; Normacol® and Klean-Prep, gastrointestinal products; and Imunovir, an immune system modulating drug in Canada.